Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Zai Lab Ltd ADR
(NQ:
ZLAB
)
29.00
+0.87 (+3.09%)
Streaming Delayed Price
Updated: 12:27 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zai Lab Ltd ADR
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
June 30, 2023
From
Zai Lab Limited
Via
GlobeNewswire
Zai Lab Announces NDA Acceptance of Repotrectinib for Patients with ROS1-positive NSCLC by China’s NMPA
June 28, 2023
From
Zai Lab Limited
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Zai Lab, Hayward, Ascendis, and Alvotech and Encourages Investors to Contact the Firm
June 25, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Why Shares of Zai Lab Are Dropping Wednesday
June 07, 2023
The company released a phase 3 trial regarding a non-small cell lung cancer therapy.
Via
The Motley Fool
Zai Lab: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Earnings Preview For Zai Lab
May 08, 2023
Via
Benzinga
ZLAB LOSS ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Zai Lab Limited Investors to Inquire About Securities Class Action Investigation - ZLAB
June 23, 2023
WHY: New York, NY - (NewMediaWire) - June 23, 2023 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zai Lab...
Via
NewMediaWire
ZAI LAB ALERT: Bragar Eagel & Squire, P.C. is Investigating Zai Lab Limited on Behalf of Zai Lab Stockholders and Encourages Investors to Contact the Firm
June 21, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation - ZLAB
June 16, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ZLAB INVESTOR NEWS: ROSEN, A LEADING LAW FIRM, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation – ZLAB
June 14, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
EQUITY ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation – ZLAB
June 08, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 07, 2023
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 07, 2023
Via
Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the Firm
June 07, 2023
From
The Schall Law Firm
Via
Business Wire
Why Yext Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
June 07, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 07, 2023
We're starting the day off right with a breakdown of the biggest pre-market stock movers worth reading about on Wednesday!
Via
InvestorPlace
Calavo Growers, Mondee Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 07, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the Firm
June 06, 2023
From
The Schall Law Firm
Via
Business Wire
Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts
June 06, 2023
Via
Benzinga
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
June 06, 2023
From
Zai Lab Limited
Via
GlobeNewswire
Zscaler, MongoDB, Chemours And Other Big Stocks Moving Higher On Friday
June 02, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Zai Lab to Highlight New Data from its Oncology Pipeline at 2023 ASCO Annual Meeting
June 01, 2023
From
Zai Lab Limited
Via
GlobeNewswire
Intel, Noah Holdings, Twilio And Other Big Stocks Moving Higher On Wednesday
May 31, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. SunCar Technology Group Inc. (NASDAQ: SDA) shares gained...
Via
Benzinga
Zai Lab Announces Participation in June Investor Conferences
May 25, 2023
From
Zai Lab Limited
Via
GlobeNewswire
Why Shares of Alibaba, PDD, and Zai Lab Are Rising Today
May 22, 2023
Several Chinese stocks rose today after positive sentiment from Wall Street and recent comments made by President Biden.
Via
The Motley Fool
Zai Lab Announces That Repotrectinib Granted Priority Review by China’s NMPA
May 18, 2023
From
Zai Lab Limited
Via
GlobeNewswire
Zai Lab Announces First Quarter 2023 Financial Results and Corporate Updates
May 09, 2023
From
Zai Lab Limited
Via
GlobeNewswire
Earnings Scheduled For May 9, 2023
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
Via
Benzinga
Zai Lab Announces Strategic Partnership and Global License Agreement with MediLink Therapeutics for a Next Generation Antibody-Drug Conjugate Program in Oncology
April 27, 2023
YL212 expands Zai Lab’s lung cancer franchise and enriches its global oncology pipeline with a potential first-in-class ADC
From
Zai Lab Limited
Via
GlobeNewswire
Zai Lab Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
April 26, 2023
From
Zai Lab Limited
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.